» Articles » PMID: 35340488

Acute Primary Angle Closure Caused by Plateau Iris After Ritodrine Use in a Primigravid Woman Successfully Treated With Clear-Lens Extraction: A Case Report

Overview
Journal Cureus
Date 2022 Mar 28
PMID 35340488
Authors
Affiliations
Soon will be listed here.
Abstract

Acute primary angle closure (APAC) is rare in young adults (those under approximately 40 years old) and pregnant women. Here, we report the case of a 37-year-old primigravid woman with APAC caused by plateau iris after the use of ritodrine (a β2 stimulator) that was successfully resolved by clear-lens extraction five months after delivery. The patient presented with pain in her right eye after ritodrine infusion for threatened premature labor at 23 weeks of gestation. Her visual acuity was 20/40, and her intraocular pressure (IOP) was 31 mmHg in her right eye. The patient was diagnosed as having APAC with plateau iris based on ultrasound biomicroscopy (UBM) findings of irido-angle touch, anterior dislocation of the ciliary process, and an absent ciliary sulcus. The effectiveness of treatment with pilocarpine eyedrops was limited, and argon laser peripheral iridoplasty did not succeed in reducing IOP. An immediate resolution was achieved with clear-lens extraction. IOP has since stayed within 14-16 mmHg without any medication for seven years. This is the first reported case of APAC complicated with plateau iris after ritodrine use in a pregnant woman. This condition is rare in young adults, making it difficult to diagnose; however, UBM can be of great help. In this case, clear-lens extraction led to a successful outcome. Our case suggests that attention should be paid to drug associations when APAC occurs with plateau iris.

Citing Articles

Plateau Iris: A Review.

Tabatabaei S, Fakhraie G, Ansari S, Hamzeh N, Safizadeh M, Beikmarzehei A J Curr Ophthalmol. 2023; 35(1):11-16.

PMID: 37680292 PMC: 10481971. DOI: 10.4103/joco.joco_319_22.


Influence of Pilocarpine Eyedrops on the Ocular Biometric Parameters and Intraocular Lens Power Calculation.

Gao R, Liu J, Zhou X, Huang L, Huang W, Xue Y J Ophthalmol. 2023; 2023:7680659.

PMID: 37455794 PMC: 10348856. DOI: 10.1155/2023/7680659.

References
1.
Subak-Sharpe I, Low S, Nolan W, Foster P . Pharmacological and environmental factors in primary angle-closure glaucoma. Br Med Bull. 2009; 93:125-43. DOI: 10.1093/bmb/ldp042. View

2.
Nongpiur M, Verma S, Tun T, Wong T, Perera S, Aung T . Plateau Iris and Severity of Primary Angle Closure Glaucoma. Am J Ophthalmol. 2020; 220:1-8. DOI: 10.1016/j.ajo.2020.07.033. View

3.
Viet Tran H, Liebmann J, Ritch R . Iridociliary apposition in plateau iris syndrome persists after cataract extraction. Am J Ophthalmol. 2002; 135(1):40-3. DOI: 10.1016/s0002-9394(02)01842-1. View

4.
Zetterstrom C, Hahnenberger R . Pharmacological characterization of human ciliary muscle adrenoceptors in vitro. Exp Eye Res. 1988; 46(3):421-30. DOI: 10.1016/s0014-4835(88)80030-7. View

5.
Rajjoub L, Chadha N, Belyea D . Intermittent acute angle closure glaucoma and chronic angle closure following topiramate use with plateau iris configuration. Clin Ophthalmol. 2014; 8:1351-4. PMC: 4109630. DOI: 10.2147/OPTH.S65748. View